Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments

ConditionObesity
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age21-75
SponsorNational Heart, Lung, and Blood Institute (NHLBI)

About this trial

Background

Obesity and physical inactivity contribute substantially to cardiovascular disease risk, diabetes, hypertension, and dyslipidemia. African American women experience disproportionately high rates of obesity and have among the lowest levels of physical activity and greatest sedentary time in the United States. Resource-limited neighborhoods may further constrain physical activity through limited access to safe parks, recreation facilities, walking routes, and other health-promoting resources.

This protocol builds on prior community-based work in Washington, D.C., which demonstrated the feasibility of wearable activity monitoring among predominantly African American women in faith-based, lower-resource communities. It uses community-based participatory research principles and mobile health technology to deliver physical-activity coaching tailored either to individual factors or to available neighborhood resources.

Objectives

Primary objective

To determine whether initiating an adaptive physical-activity intervention with remote, mobile-app coaching tailored to neighborhood physical-activity resources "tailored-to-place" coaching-produces a greater increase in steps per day over approximately three months than standard remote coaching.

Secondary objectives

The study will also:

Compare four embedded adaptive intervention strategies over approximately six months.

Assess the feasibility of remotely measuring weight, blood pressure, and blood glucose using connected devices.

Evaluate effects on cardiometabolic measures, including BMI, blood pressure, lipids, glucose, dietary intake, self-reported physical activity, and smoking.

Examine inflammatory, lipid, immunometabolic, psychosocial, behavioral, and social-determinants-of-health pathways related to physical-activity change.

Evaluate changes in cardiac structure and function and body composition using optional cardiovascular and body-composition MRI.

Assess relationships among sleep, ambulatory blood pressure, menopause-related factors, and immunometabolic markers in a postmenopausal sleep sub-study.

Conduct user-centered testing of the mobile application and wearable/mobile health technologies.

Explore COVID-19 exposure and pandemic-related psychosocial stress as potential confounders of immunologic and psychosocial outcomes.

Eligibility: Inclusion Criteria

Participants must:

Be African American women aged 21-75 years.

Have overweight or obesity, defined as BMI \>=25 kg/m\^2

Live in Washington, D.C., Wards 5, 7, or 8, or in neighboring areas of Prince George's County, Maryland.

Have access to a smartphone compatible with the study application.

Be able to provide informed consent independently.

Speak and read English at approximately an eighth-grade level.

Participants enter a two-week run-in period. Those averaging 7,500 steps per day or fewer and who complete the run-in are eligible for randomization into the intervention.

Main study exclusion criteria

Potential participants are excluded for conditions that could make increased physical activity unsafe or interfere with study assessments, including:

Medical conditions or physical limitations that prohibit safe participation in physical activity.

Recent myocardial infarction, documented obstructive coronary artery disease, recent coronary stenting, or significant decompensated structural heart disease.

Pregnancy; pregnancy status is assessed as applicable during study visits.

Other conditions determined by the investigator to make participation unsafe.

Sleep sub-study eligibility

The optional sleep sub-study is limited to postmenopausal women who are enrolled in or have completed the main study. Additional exclusions include night-shift work, conditions that interfere with overnight polysomnography, recent initiation of sleep-modifying medications, inability to tolerate ambulatory blood-pressure monitoring, and certain arm, vascular, skin, bleeding, or neurologic conditions.

MRI participation is optional and requires separate screening for MRI-incompatible implanted devices or metal and, when applicable, eligibility for gadolinium contrast.

Study design

A six-month adaptive randomized trial will enroll overweight or obese African American women. After a two-week run-in, participants averaging \<=7,500 steps/day will receive either standard mobile-app coaching or coaching tailored to neighborhood physical-activity resources. At three months, nonresponders will be reassigned to intensified coaching. Steps will be measured with a wearable device, with assessments at baseline, three months, and six months. Optional monitoring and MRI/sleep sub-studies will assess cardiometabolic outcomes.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

Medical condition, including heart failure, recent unintentional weight loss or physical limitation, that might prohibit safe participation in physical activity for any reason

Heart disease as indicated by history of myocardial infarction in past 1 year, documented obstructive coronary artery disease on coronary angiography, coronary artery stent placement within the last year significant structural heart disease (e.g. hypertrophic or dilated cardiomyopathy with EF <35%, severe valvular heart disease) with evidence of decompensation.

Pregnant women due to large hormonal changes during pregnancy that affect study variables and potential pregnancy-related restrictions on exercise. All participants of childbearing potential will need to self-report a negative pregnancy at the screening visit, baseline visit, and at the three-month and six-month visits, unless the participant self-reports being postmenopausal, having had a tubal ligation, or having undergone a complete hysterectomy.

Must be an African-American female

Trial design

Design model

Sequential

Treatments tested in this trial

  • AMRA(r) Researcher Image reconstruction software

    Device

    Image reconstruction software

  • MRI: radiofrequency coils (Device Manufacturer: Siemens Medical Solutions USA, Inc.)

    Device

    radiofrequency coils

  • MRI: Research pulse sequences (Device Manufacturer: NIH)

    Device

    pulse sequences

  • MRI: Image Reconstruction and Analysis Software (Device Manufacturer: NIH)

    Device

    Image Reconstruction and Analysis Software

  • Bluetooth-enabled glucometer

    Device

    Bluetooth-enabled glucometer

  • Remote tailored-to-place coaching (TPC)

    Device

    Provides SRC components plus recommendations based on physical-activity resources near the participant s home, work, or church. Messages may recommend parks, recreation centers, exercise classes, trails, greenspaces, or walking routes within an approximately 0.75-mile radius.

  • Standard remote coaching (SRC)

    Other intervention

    Provides individual-level physical-activity coaching based on goal setting, self-efficacy, barriers, personal preferences, and step data. Educational content is adapted from the Diabetes Prevention Program. Messaging encourages progression toward 10,000 steps/day.

  • Run-in physical-activity monitoring

    Device

    Participants self-monitor activity during an approximately 2-week run-in period without receiving intervention messaging. Participants averaging 7,500 steps/day proceed to randomization.

  • Ambulatory blood-pressure monitor

    Device

    Measures systolic and diastolic blood pressure and pulse over approximately 48 hours during usual daily activities.

  • Polysomnography equipment

    Device

    Overnight monitoring using EEG, EOG, EMG, ECG, respiratory airflow and effort, oxygen saturation, body position, snoring, and leg-movement sensors to characterize sleep, including slow-wave sleep.

Treatment groups

325 Participants
are divided into 2 treatment groups
Group A: Group 2 Label: PA monitor with standard remote coaching (SRC)Other 10 interventions
Group B: Group 1 Label: PA monitor with remote coaching tailored to placeOther 10 interventions

Trial outcomes

Primary outcomes

1

Change in physical activity, measured as average steps per day

Compare the change in objectively measured daily step counts between participants initially assigned to remote coaching tailored to neighborhood physical-activity resources (tailored-to-place coaching) and those assigned to standard remote coaching. Steps are captured by a wrist-worn physical-activity monitor and summarized as average steps per day. The protocol's primary treatment effect is based on the average weekly step counts during the final four weeks of the six-month intervention, approximately weeks 21-24 for the longer-term adaptive intervention analysis.

Time frame
Baseline/run-in through approximately 3 months after randomization

Secondary outcomes

1

Cardiac structure, function, and perfusion

Assess changes in biventricular and left-ventricular structure and function, myocardial characteristics, and vasodilator stress perfusion using cardiovascular magnetic resonance in an optional subset.

Time frame
Optional CMR during the run-in/baseline period and again within the month-6 visit window
2

Mobile-health technology feasibility and acceptability

Evaluate usability, acceptability, functionality, engagement, message delivery, app use, wearable-device adherence, and completion of ecological momentary assessments and educational modules.

Time frame
Pilot period of approximately 23 days; intervention period up to approximately 6.5 months
3

Psychosocial and behavioral mediators

Assess chronic psychological and environmental stress, social support and isolation, perceived discrimination, neighborhood environment, sedentary behavior, sleep quality and duration, and other factors that may mediate or modify the relationship between physical activity and cardiovascular health.

Time frame
Baseline, approximately 3 months, and approximately 6 months
4

Inflammatory and immunometabolic biomarkers

Characterize changes associated with increasing physical activity in cytokines, chemokines, lipid inflammatory intermediates, vascular/endothelial markers, immune-cell measures, and related inflammatory pathways.

Time frame
Baseline, approximately 3 months, and approximately 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.